This is a phase one study to assess the safety of daily dosing of Lactobacillus reuteri in healthy adults in Peru. It is conducted as a preliminary study in support of a clinical trial to assess safety and efficacy of Lactobacillus reuteri versus placebo for treatment of pediatric diarrhea in Peru.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With a Positive Blood Culture for L. Reuteri
Timeframe: participants were followed for an average of 36 days
Mean Daily Temperature
Timeframe: 5 days of study product administration
Leukocyte Count on Day 5
Timeframe: Measured on day 5
Serum Alanine Aminotransferase (ALT) in Female Participants
Timeframe: Day 5
Serum ALT in Males
Timeframe: Day 5
Serum Aspartate Aminotransferase (AST) in Females
Timeframe: Day 5
Serum AST in Males
Timeframe: Day 5
Blood Urea Nitrogen
Timeframe: Day 5
Serum Creatinine
Timeframe: Day 5